ID24374A - Komposisi-komposisi parenteral alatrofloksasin - Google Patents

Komposisi-komposisi parenteral alatrofloksasin

Info

Publication number
ID24374A
ID24374A IDW20000200A ID20000200A ID24374A ID 24374 A ID24374 A ID 24374A ID W20000200 A IDW20000200 A ID W20000200A ID 20000200 A ID20000200 A ID 20000200A ID 24374 A ID24374 A ID 24374A
Authority
ID
Indonesia
Prior art keywords
alatrofloxasin
parenteral compositions
parenteral
compositions
Prior art date
Application number
IDW20000200A
Other languages
English (en)
Indonesian (id)
Inventor
Robert Mark Guinn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24374A publication Critical patent/ID24374A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20000200A 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin ID24374A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ID24374A true ID24374A (id) 2000-07-13

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000200A ID24374A (id) 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
CA2444597A1 (fr) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
CA2508792C (fr) 2002-12-06 2013-02-05 Affinium Pharmaceuticals, Inc. Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
WO2004082586A2 (fr) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
CA2568914C (fr) * 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Agents therapeutiques, et methodes de fabrication et d'utilisation
EP1973902A2 (fr) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. Agents therapeutiques et ses procédés de fabrication et d utilisation
EP2687533B1 (fr) 2006-07-20 2017-07-19 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
SMT201900411T1 (it) 2012-06-19 2019-09-09 Debiopharm Int Sa Derivati di profaramci di (e)-n-metil-n-((3-metilbenzofuran-2-il)metil -3-(7-osso-5,6,7,8-tetraidro-1,8-naftiridin-3-il)acrilammide
KR20160144499A (ko) * 2014-04-25 2016-12-16 노렉스, 인크. 신경활성 펩타이드의 안정한 조성물
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
WO2019148294A1 (fr) 2018-02-02 2019-08-08 Interface Biologics, Inc. Compositions de promédicaments de dexaméthasone dimères et leurs utilisations
US12473326B2 (en) 2019-02-01 2025-11-18 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
FI3923914T3 (fi) 2019-02-14 2023-04-27 Debiopharm Int Sa Afabisiiniformulaatio, menetelmä sen valmistamiseksi
MA56184A (fr) 2019-06-14 2022-04-20 Debiopharm Int Sa Afabicine pour utilisation dans le traitement d'infections bactériennes impliquant un biofilm
US20220347305A1 (en) 2019-08-07 2022-11-03 Ripple Therapeutics Corporation Controlled release drug dimers
WO2021220061A2 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions hétérodimères et méthodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
PL179996B1 (en) 1994-01-18 2000-11-30 Pfizer Method of and intermediate products for obtaining salts of naphtyridinocarboxylic acids
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
JP3145715B2 (ja) 1995-06-06 2001-03-12 ファイザー・インコーポレーテッド 無水７−（［１α，５α，６α］−６−アミノ−３−アザビシクロ［３．１．０］ヘキサ−３−イル）−６−フルオロ−１−（２，４−ジフルオロフェニル）−１，４−ジヒドロ−４−オキソ−１，８−ナフチリディン−３−カルボン酸メタンスルホン酸塩の新規な結晶形態
US5939550A (en) * 1995-06-15 1999-08-17 Pfizer Inc. Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
NZ312199A (en) 1995-08-29 1999-06-29 Pfizer Zwitterionic forms of trovafloxacin
EP0847400B1 (fr) * 1995-08-29 2001-11-14 Pfizer Inc. Polymorphes du promedicament 6-n-(l-ala-l-ala)-trovafloxacine
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
BG104105A (bg) 2000-08-31
DE69821767T2 (de) 2005-01-13
CN1265671A (zh) 2000-09-06
CA2296466A1 (fr) 1999-02-11
PE103799A1 (es) 1999-10-25
IL134156A0 (en) 2001-04-30
PA8456701A1 (es) 2000-05-24
HRP980417A2 (en) 1999-08-31
PT1000086E (pt) 2004-05-31
UY25113A1 (es) 2000-12-29
JP3463928B2 (ja) 2003-11-05
DZ2576A1 (fr) 2003-02-22
GT199800112A (es) 2000-01-15
DK1000086T3 (da) 2004-05-17
YU2500A (sh) 2002-09-19
HN1998000106A (es) 1999-01-08
AR015417A1 (es) 2001-05-02
AP1031A (en) 2001-12-21
HUP0004793A3 (en) 2001-10-29
AU8236898A (en) 1999-02-22
SK1012000A3 (en) 2000-09-12
KR20010022495A (ko) 2001-03-15
EA200000086A1 (ru) 2000-08-28
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
ATE259827T1 (de) 2004-03-15
WO1999006430A1 (fr) 1999-02-11
AU734863B2 (en) 2001-06-21
NZ502249A (en) 2001-11-30
DE69821767D1 (de) 2004-03-25
MA24626A1 (fr) 1999-04-01
CA2296466C (fr) 2003-04-15
ZA986874B (en) 2000-01-31
BR9811580A (pt) 2000-08-22
HUP0004793A2 (hu) 2001-04-28
ES2214716T3 (es) 2004-09-16
AP9801310A0 (en) 1998-09-30
HRP980417B1 (en) 2002-10-31
EP1000086A1 (fr) 2000-05-17
EA002120B1 (ru) 2001-12-24
OA11281A (en) 2002-11-19
NO20000485L (no) 2000-03-27
TNSN98146A1 (fr) 2005-03-15
IS5339A (is) 2000-01-14
JP2001512133A (ja) 2001-08-21
US6194429B1 (en) 2001-02-27
CO4970688A1 (es) 2000-11-07
EP1000086B1 (fr) 2004-02-18
NO20000485D0 (no) 2000-01-31

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
ID16251A (id) Komposisi-komposisi pembasmi kuman
PT945132E (pt) Composicao de ibuprofeno
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI974241A0 (fi) BPM-15 -koostumukset
DE69803761D1 (de) Schmierölzusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID25508A (id) Komposisi dematologis
ID24458A (id) Modifikasi rheologi in-sito poliolefin
PT1014987E (pt) Composicoes orais de levosimendano
DE69927758D1 (de) Imidosilan-Zusammensetzungen
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ATE293672T1 (de) Farbschonende zusammensetzungen
DE69617029D1 (de) Organoton-zusammensetzungen
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
MA24626A1 (fr) Compositions parenterales d'alatrofloxacine
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
DK0975348T3 (da) Stabiliserede tibolon-sammensætninger